CEGAT GMBH
Desconocido
COSYN: Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders
CEGAT GMBH
participó en un
H2020:
H2020-PHC-2014-2015
COSYN integrates outstanding European academic and three large Pharma to exploit genomic findings for intellectual disability (ID), autism,...
2015-12-09 - 2020-12-31 | Financiado
2015-12-09 - 2020-12-31 | Financiado
CAM-PAC: Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer
CEGAT GMBH
participó en un
FP7:
Cancers are genetic disease arising from the accumulation of multiple molecular alterations in affected cells. Large-scale genomic, transcri...
Financiado
Financiado
DESIRE: Development and Epilepsy Strategies for Innovative Research to improve diagnosis prevention and t...
CEGAT GMBH
participó en un
FP7:
DESIRE will focus on epileptogenic developmental disorders EDD, i.e. early onset epilepsies whose origin is closely related to developmental...
Financiado
Financiado
* No se disponen de datos de la empresa actual.